<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 24 Apr 2024 06:12:40 +0000</lastbuilddate>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>RNA-based therapies targeting APOC3 lower triglyceride levels in patients with hypertriglyceridaemia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38654089/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 23. doi: 10.1038/s41569-024-01034-w. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38654089/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38654089</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01034-w>10.1038/s41569-024-01034-w</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38654089</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Karina Huynh</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>RNA-based therapies targeting APOC3 lower triglyceride levels in patients with hypertriglyceridaemia</dc:title>
<dc:identifier>pmid:38654089</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01034-w</dc:identifier>
</item>
<item>
<title>Heart pump increases survival in STEMI-related cardiogenic shock</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38654088/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 23. doi: 10.1038/s41569-024-01035-9. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38654088/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38654088</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01035-9>10.1038/s41569-024-01035-9</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38654088</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jennifer Harman</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Heart pump increases survival in STEMI-related cardiogenic shock</dc:title>
<dc:identifier>pmid:38654088</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01035-9</dc:identifier>
</item>
<item>
<title>Benefits of ninerafaxstat in non-obstructive hypertrophic cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38654087/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 23. doi: 10.1038/s41569-024-01032-y. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38654087/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38654087</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01032-y>10.1038/s41569-024-01032-y</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38654087</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Gregory B Lim</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Benefits of ninerafaxstat in non-obstructive hypertrophic cardiomyopathy</dc:title>
<dc:identifier>pmid:38654087</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01032-y</dc:identifier>
</item>
<item>
<title>Strategies for the delivery of sex-based equity in cardiovascular clinical trials</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38654086/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 23. doi: 10.1038/s41569-024-01025-x. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38654086/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38654086</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01025-x>10.1038/s41569-024-01025-x</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38654086</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Julie Sanders</dc:creator>
<dc:creator>Tim Clayton</dc:creator>
<dc:creator>Stacey Matthews</dc:creator>
<dc:creator>Sarah Murray</dc:creator>
<dc:creator>Lynn Laidlaw</dc:creator>
<dc:creator>Richard Evans</dc:creator>
<dc:creator>Rochelle Wynne</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Strategies for the delivery of sex-based equity in cardiovascular clinical trials</dc:title>
<dc:identifier>pmid:38654086</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01025-x</dc:identifier>
</item>
<item>
<title>BCAA-nitrogen flux in brown fat controls metabolic health independent of thermogenesis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38653240/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>Brown adipose tissue (BAT) is best known for thermogenesis. Rodent studies demonstrated that enhanced BAT thermogenesis is tightly associated with increased energy expenditure, reduced body weight, and improved glucose homeostasis. However, human BAT is protective against type 2 diabetes, independent of body weight. The mechanism underlying this dissociation remains unclear. Here, we report that impaired mitochondrial catabolism of branched-chain amino acids (BCAAs) in BAT, by deleting...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 17:S0092-8674(24)00346-5. doi: 10.1016/j.cell.2024.03.030. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Brown adipose tissue (BAT) is best known for thermogenesis. Rodent studies demonstrated that enhanced BAT thermogenesis is tightly associated with increased energy expenditure, reduced body weight, and improved glucose homeostasis. However, human BAT is protective against type 2 diabetes, independent of body weight. The mechanism underlying this dissociation remains unclear. Here, we report that impaired mitochondrial catabolism of branched-chain amino acids (BCAAs) in BAT, by deleting mitochondrial BCAA carriers (MBCs), caused systemic insulin resistance without affecting energy expenditure and body weight. Brown adipocytes catabolized BCAA in the mitochondria as nitrogen donors for the biosynthesis of non-essential amino acids and glutathione. Impaired mitochondrial BCAA-nitrogen flux in BAT resulted in increased oxidative stress, decreased hepatic insulin signaling, and decreased circulating BCAA-derived metabolites. A high-fat diet attenuated BCAA-nitrogen flux and metabolite synthesis in BAT, whereas cold-activated BAT enhanced the synthesis. This work uncovers a metabolite-mediated pathway through which BAT controls metabolic health beyond thermogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38653240/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38653240</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.030>10.1016/j.cell.2024.03.030</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38653240</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Anthony R P Verkerke</dc:creator>
<dc:creator>Dandan Wang</dc:creator>
<dc:creator>Naofumi Yoshida</dc:creator>
<dc:creator>Zachary H Taxin</dc:creator>
<dc:creator>Xu Shi</dc:creator>
<dc:creator>Shuning Zheng</dc:creator>
<dc:creator>Yuka Li</dc:creator>
<dc:creator>Christopher Auger</dc:creator>
<dc:creator>Satoshi Oikawa</dc:creator>
<dc:creator>Jin-Seon Yook</dc:creator>
<dc:creator>Melia Granath-Panelo</dc:creator>
<dc:creator>Wentao He</dc:creator>
<dc:creator>Guo-Fang Zhang</dc:creator>
<dc:creator>Mami Matsushita</dc:creator>
<dc:creator>Masayuki Saito</dc:creator>
<dc:creator>Robert E Gerszten</dc:creator>
<dc:creator>Evanna L Mills</dc:creator>
<dc:creator>Alexander S Banks</dc:creator>
<dc:creator>Yasushi Ishihama</dc:creator>
<dc:creator>Phillip J White</dc:creator>
<dc:creator>Robert W McGarrah</dc:creator>
<dc:creator>Takeshi Yoneshiro</dc:creator>
<dc:creator>Shingo Kajimura</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>BCAA-nitrogen flux in brown fat controls metabolic health independent of thermogenesis</dc:title>
<dc:identifier>pmid:38653240</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.030</dc:identifier>
</item>
<item>
<title>Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38653239/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>The gut microbiota has been found to play an important role in the progression of metabolic dysfunction-associated steatohepatitis (MASH), but the mechanisms have not been established. Here, by developing a click-chemistry-based enrichment strategy, we identified several microbial-derived bile acids, including the previously uncharacterized 3-succinylated cholic acid (3-sucCA), which is negatively correlated with liver damage in patients with liver-tissue-biopsy-proven metabolic...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 17:S0092-8674(24)00350-7. doi: 10.1016/j.cell.2024.03.034. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The gut microbiota has been found to play an important role in the progression of metabolic dysfunction-associated steatohepatitis (MASH), but the mechanisms have not been established. Here, by developing a click-chemistry-based enrichment strategy, we identified several microbial-derived bile acids, including the previously uncharacterized 3-succinylated cholic acid (3-sucCA), which is negatively correlated with liver damage in patients with liver-tissue-biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). By screening human bacterial isolates, we identified Bacteroides uniformis strains as effective producers of 3-sucCA both in vitro and in vivo. By activity-based protein purification and identification, we identified an enzyme annotated as β-lactamase in B. uniformis responsible for 3-sucCA biosynthesis. Furthermore, we found that 3-sucCA is a lumen-restricted metabolite and alleviates MASH by promoting the growth of Akkermansia muciniphila. Together, our data offer new insights into the gut microbiota-liver axis that may be leveraged to augment the management of MASH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38653239/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38653239</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.034>10.1016/j.cell.2024.03.034</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38653239</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Qixing Nie</dc:creator>
<dc:creator>Xi Luo</dc:creator>
<dc:creator>Kai Wang</dc:creator>
<dc:creator>Yong Ding</dc:creator>
<dc:creator>Shumi Jia</dc:creator>
<dc:creator>Qixiang Zhao</dc:creator>
<dc:creator>Meng Li</dc:creator>
<dc:creator>Jinxin Zhang</dc:creator>
<dc:creator>Yingying Zhuo</dc:creator>
<dc:creator>Jun Lin</dc:creator>
<dc:creator>Chenghao Guo</dc:creator>
<dc:creator>Zhiwei Zhang</dc:creator>
<dc:creator>Huiying Liu</dc:creator>
<dc:creator>Guangyi Zeng</dc:creator>
<dc:creator>Jie You</dc:creator>
<dc:creator>Lulu Sun</dc:creator>
<dc:creator>Hua Lu</dc:creator>
<dc:creator>Ming Ma</dc:creator>
<dc:creator>Yanxing Jia</dc:creator>
<dc:creator>Ming-Hua Zheng</dc:creator>
<dc:creator>Yanli Pang</dc:creator>
<dc:creator>Jie Qiao</dc:creator>
<dc:creator>Changtao Jiang</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway</dc:title>
<dc:identifier>pmid:38653239</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.034</dc:identifier>
</item>
<item>
<title>Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38653238/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>Lysine lactylation is a post-translational modification that links cellular metabolism to protein function. Here, we find that AARS1 functions as a lactate sensor that mediates global lysine lacylation in tumor cells. AARS1 binds to lactate and catalyzes the formation of lactate-AMP, followed by transfer of lactate to the lysince acceptor residue. Proteomics studies reveal a large number of AARS1 targets, including p53 where lysine 120 and lysine 139 in the DNA binding domain are lactylated....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 17:S0092-8674(24)00397-0. doi: 10.1016/j.cell.2024.04.002. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Lysine lactylation is a post-translational modification that links cellular metabolism to protein function. Here, we find that AARS1 functions as a lactate sensor that mediates global lysine lacylation in tumor cells. AARS1 binds to lactate and catalyzes the formation of lactate-AMP, followed by transfer of lactate to the lysince acceptor residue. Proteomics studies reveal a large number of AARS1 targets, including p53 where lysine 120 and lysine 139 in the DNA binding domain are lactylated. Generation and utilization of p53 variants carrying constitutively lactylated lysine residues revealed that AARS1 lactylation of p53 hinders its liquid-liquid phase separation, DNA binding, and transcriptional activation. AARS1 expression and p53 lacylation correlate with poor prognosis among cancer patients carrying wild type p53. β-alanine disrupts lactate binding to AARS1, reduces p53 lacylation, and mitigates tumorigenesis in animal models. We propose that AARS1 contributes to tumorigenesis by coupling tumor cell metabolism to proteome alteration.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38653238/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38653238</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.002>10.1016/j.cell.2024.04.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38653238</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Zhi Zong</dc:creator>
<dc:creator>Feng Xie</dc:creator>
<dc:creator>Shuai Wang</dc:creator>
<dc:creator>Xiaojin Wu</dc:creator>
<dc:creator>Zhenyu Zhang</dc:creator>
<dc:creator>Bing Yang</dc:creator>
<dc:creator>Fangfang Zhou</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis</dc:title>
<dc:identifier>pmid:38653238</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.002</dc:identifier>
</item>
<item>
<title>DrugMap: A quantitative pan-cancer analysis of cysteine ligandability</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38653237/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>Cysteine-focused chemical proteomic platforms have accelerated the clinical development of covalent inhibitors for a wide range of targets in cancer. However, how different oncogenic contexts influence cysteine targeting remains unknown. To address this question, we have developed "DrugMap," an atlas of cysteine ligandability compiled across 416 cancer cell lines. We unexpectedly find that cysteine ligandability varies across cancer cell lines, and we attribute this to differences in cellular...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 17:S0092-8674(24)00318-0. doi: 10.1016/j.cell.2024.03.027. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cysteine-focused chemical proteomic platforms have accelerated the clinical development of covalent inhibitors for a wide range of targets in cancer. However, how different oncogenic contexts influence cysteine targeting remains unknown. To address this question, we have developed "DrugMap," an atlas of cysteine ligandability compiled across 416 cancer cell lines. We unexpectedly find that cysteine ligandability varies across cancer cell lines, and we attribute this to differences in cellular redox states, protein conformational changes, and genetic mutations. Leveraging these findings, we identify actionable cysteines in NF-κB1 and SOX10 and develop corresponding covalent ligands that block the activity of these transcription factors. We demonstrate that the NF-κB1 probe blocks DNA binding, whereas the SOX10 ligand increases SOX10-SOX10 interactions and disrupts melanoma transcriptional signaling. Our findings reveal heterogeneity in cysteine ligandability across cancers, pinpoint cell-intrinsic features driving cysteine targeting, and illustrate the use of covalent probes to disrupt oncogenic transcription-factor activity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38653237/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38653237</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.027>10.1016/j.cell.2024.03.027</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38653237</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Mariko Takahashi</dc:creator>
<dc:creator>Harrison B Chong</dc:creator>
<dc:creator>Siwen Zhang</dc:creator>
<dc:creator>Tzu-Yi Yang</dc:creator>
<dc:creator>Matthew J Lazarov</dc:creator>
<dc:creator>Stefan Harry</dc:creator>
<dc:creator>Michelle Maynard</dc:creator>
<dc:creator>Brendan Hilbert</dc:creator>
<dc:creator>Ryan D White</dc:creator>
<dc:creator>Heather E Murrey</dc:creator>
<dc:creator>Chih-Chiang Tsou</dc:creator>
<dc:creator>Kira Vordermark</dc:creator>
<dc:creator>Jonathan Assaad</dc:creator>
<dc:creator>Magdy Gohar</dc:creator>
<dc:creator>Benedikt R Dürr</dc:creator>
<dc:creator>Marianne Richter</dc:creator>
<dc:creator>Himani Patel</dc:creator>
<dc:creator>Gregory Kryukov</dc:creator>
<dc:creator>Natasja Brooijmans</dc:creator>
<dc:creator>Aliyu Sidi Omar Alghali</dc:creator>
<dc:creator>Karla Rubio</dc:creator>
<dc:creator>Antonio Villanueva</dc:creator>
<dc:creator>Junbing Zhang</dc:creator>
<dc:creator>Maolin Ge</dc:creator>
<dc:creator>Farah Makram</dc:creator>
<dc:creator>Hanna Griesshaber</dc:creator>
<dc:creator>Drew Harrison</dc:creator>
<dc:creator>Ann-Sophie Koglin</dc:creator>
<dc:creator>Samuel Ojeda</dc:creator>
<dc:creator>Barbara Karakyriakou</dc:creator>
<dc:creator>Alexander Healy</dc:creator>
<dc:creator>George Popoola</dc:creator>
<dc:creator>Inbal Rachmin</dc:creator>
<dc:creator>Neha Khandelwal</dc:creator>
<dc:creator>Jason R Neil</dc:creator>
<dc:creator>Pei-Chieh Tien</dc:creator>
<dc:creator>Nicholas Chen</dc:creator>
<dc:creator>Tobias Hosp</dc:creator>
<dc:creator>Sanne van den Ouweland</dc:creator>
<dc:creator>Toshiro Hara</dc:creator>
<dc:creator>Lillian Bussema</dc:creator>
<dc:creator>Rui Dong</dc:creator>
<dc:creator>Lei Shi</dc:creator>
<dc:creator>Martin Q Rasmussen</dc:creator>
<dc:creator>Ana Carolina Domingues</dc:creator>
<dc:creator>Aleigha Lawless</dc:creator>
<dc:creator>Jacy Fang</dc:creator>
<dc:creator>Satoshi Yoda</dc:creator>
<dc:creator>Linh Phuong Nguyen</dc:creator>
<dc:creator>Sarah Marie Reeves</dc:creator>
<dc:creator>Farrah Nicole Wakefield</dc:creator>
<dc:creator>Adam Acker</dc:creator>
<dc:creator>Sarah Elizabeth Clark</dc:creator>
<dc:creator>Taronish Dubash</dc:creator>
<dc:creator>John Kastanos</dc:creator>
<dc:creator>Eugene Oh</dc:creator>
<dc:creator>David E Fisher</dc:creator>
<dc:creator>Shyamala Maheswaran</dc:creator>
<dc:creator>Daniel A Haber</dc:creator>
<dc:creator>Genevieve M Boland</dc:creator>
<dc:creator>Moshe Sade-Feldman</dc:creator>
<dc:creator>Russell W Jenkins</dc:creator>
<dc:creator>Aaron N Hata</dc:creator>
<dc:creator>Nabeel M Bardeesy</dc:creator>
<dc:creator>Mario L Suvà</dc:creator>
<dc:creator>Brent R Martin</dc:creator>
<dc:creator>Brian B Liau</dc:creator>
<dc:creator>Christopher J Ott</dc:creator>
<dc:creator>Miguel N Rivera</dc:creator>
<dc:creator>Michael S Lawrence</dc:creator>
<dc:creator>Liron Bar-Peled</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>DrugMap: A quantitative pan-cancer analysis of cysteine ligandability</dc:title>
<dc:identifier>pmid:38653237</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.027</dc:identifier>
</item>
<item>
<title>Integrative spatial analysis reveals a multi-layered organization of glioblastoma</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38653236/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>Glioma contains malignant cells in diverse states. Here, we combine spatial transcriptomics, spatial proteomics, and computational approaches to define glioma cellular states and uncover their organization. We find three prominent modes of organization. First, gliomas are composed of small local environments, each typically enriched with one major cellular state. Second, specific pairs of states preferentially reside in proximity across multiple scales. This pairing of states is consistent...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 16:S0092-8674(24)00320-9. doi: 10.1016/j.cell.2024.03.029. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Glioma contains malignant cells in diverse states. Here, we combine spatial transcriptomics, spatial proteomics, and computational approaches to define glioma cellular states and uncover their organization. We find three prominent modes of organization. First, gliomas are composed of small local environments, each typically enriched with one major cellular state. Second, specific pairs of states preferentially reside in proximity across multiple scales. This pairing of states is consistent across tumors. Third, these pairwise interactions collectively define a global architecture composed of five layers. Hypoxia appears to drive the layers, as it is associated with a long-range organization that includes all cancer cell states. Accordingly, tumor regions distant from any hypoxic/necrotic foci and tumors that lack hypoxia such as low-grade IDH-mutant glioma are less organized. In summary, we provide a conceptual framework for the organization of cellular states in glioma, highlighting hypoxia as a long-range tissue organizer.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38653236/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38653236</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.029>10.1016/j.cell.2024.03.029</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38653236</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Alissa C Greenwald</dc:creator>
<dc:creator>Noam Galili Darnell</dc:creator>
<dc:creator>Rouven Hoefflin</dc:creator>
<dc:creator>Dor Simkin</dc:creator>
<dc:creator>Christopher W Mount</dc:creator>
<dc:creator>L Nicolas Gonzalez Castro</dc:creator>
<dc:creator>Yotam Harnik</dc:creator>
<dc:creator>Sydney Dumont</dc:creator>
<dc:creator>Dana Hirsch</dc:creator>
<dc:creator>Masashi Nomura</dc:creator>
<dc:creator>Tom Talpir</dc:creator>
<dc:creator>Merav Kedmi</dc:creator>
<dc:creator>Inna Goliand</dc:creator>
<dc:creator>Gioele Medici</dc:creator>
<dc:creator>Julie Laffy</dc:creator>
<dc:creator>Baoguo Li</dc:creator>
<dc:creator>Vamsi Mangena</dc:creator>
<dc:creator>Hadas Keren-Shaul</dc:creator>
<dc:creator>Michael Weller</dc:creator>
<dc:creator>Yoseph Addadi</dc:creator>
<dc:creator>Marian C Neidert</dc:creator>
<dc:creator>Mario L Suvà</dc:creator>
<dc:creator>Itay Tirosh</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Integrative spatial analysis reveals a multi-layered organization of glioblastoma</dc:title>
<dc:identifier>pmid:38653236</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.029</dc:identifier>
</item>
<item>
<title>Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38653235/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an activating receptor conserved among mammals that recognizes infection-induced stress ligands (e.g., MIC-A/B). We found that SARS-CoV-2 evades NKG2D recognition by surface downregulation of MIC-A/B via shedding, observed in human lung tissue and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Apr 11:S0092-8674(24)00317-9. doi: 10.1016/j.cell.2024.03.026. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an activating receptor conserved among mammals that recognizes infection-induced stress ligands (e.g., MIC-A/B). We found that SARS-CoV-2 evades NKG2D recognition by surface downregulation of MIC-A/B via shedding, observed in human lung tissue and COVID-19 patient serum. Systematic testing of SARS-CoV-2 proteins revealed that ORF6, an accessory protein uniquely conserved among sarbecoviruses, was responsible for MIC-A/B downregulation via shedding. Further investigation demonstrated that natural killer (NK) cells efficiently killed SARS-CoV-2-infected cells and limited viral spread. However, inhibition of MIC-A/B shedding with a monoclonal antibody, 7C6, further enhanced NK-cell activity toward SARS-CoV-2-infected cells. Our findings unveil a strategy employed by SARS-CoV-2 to evade cytotoxic immunity, identify the culprit immunevasin shared among sarbecoviruses, and suggest a potential novel antiviral immunotherapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38653235/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38653235</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.03.026>10.1016/j.cell.2024.03.026</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38653235</guid>
<pubDate>Tue, 23 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jordan A Hartmann</dc:creator>
<dc:creator>Marcella R Cardoso</dc:creator>
<dc:creator>Maria Cecilia Ramiro Talarico</dc:creator>
<dc:creator>Devin J Kenney</dc:creator>
<dc:creator>Madison R Leone</dc:creator>
<dc:creator>Dagny C Reese</dc:creator>
<dc:creator>Jacquelyn Turcinovic</dc:creator>
<dc:creator>Aoife K O'Connell</dc:creator>
<dc:creator>Hans P Gertje</dc:creator>
<dc:creator>Caitlin Marino</dc:creator>
<dc:creator>Pedro E Ojeda</dc:creator>
<dc:creator>Erich V De Paula</dc:creator>
<dc:creator>Fernanda A Orsi</dc:creator>
<dc:creator>Licio Augusto Velloso</dc:creator>
<dc:creator>Thomas R Cafiero</dc:creator>
<dc:creator>John H Connor</dc:creator>
<dc:creator>Alexander Ploss</dc:creator>
<dc:creator>Angelique Hoelzemer</dc:creator>
<dc:creator>Mary Carrington</dc:creator>
<dc:creator>Amy K Barczak</dc:creator>
<dc:creator>Nicholas A Crossland</dc:creator>
<dc:creator>Florian Douam</dc:creator>
<dc:creator>Julie Boucau</dc:creator>
<dc:creator>Wilfredo F Garcia-Beltran</dc:creator>
<dc:date>2024-04-23</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses</dc:title>
<dc:identifier>pmid:38653235</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.03.026</dc:identifier>
</item>
<item>
<title>No benefit of β-blockers after myocardial infarction with preserved ejection fraction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38649758/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 22. doi: 10.1038/s41569-024-01030-0. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38649758/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38649758</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01030-0>10.1038/s41569-024-01030-0</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38649758</guid>
<pubDate>Mon, 22 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Gregory B Lim</dc:creator>
<dc:date>2024-04-22</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>No benefit of β-blockers after myocardial infarction with preserved ejection fraction</dc:title>
<dc:identifier>pmid:38649758</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01030-0</dc:identifier>
</item>
<item>
<title>Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38648276/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 23;149(17):1372-1374. doi: 10.1161/CIRCULATIONAHA.124.068738. Epub 2024 Apr 22.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38648276/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38648276</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068738>10.1161/CIRCULATIONAHA.124.068738</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38648276</guid>
<pubDate>Mon, 22 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Rashmi J Rao</dc:creator>
<dc:creator>Stephen Y Chan</dc:creator>
<dc:date>2024-04-22</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:38648276</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068738</dc:identifier>
</item>
<item>
<title>Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38648275/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 23;149(17):1339-1340. doi: 10.1161/CIRCULATIONAHA.124.069354. Epub 2024 Apr 22.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38648275/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38648275</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069354>10.1161/CIRCULATIONAHA.124.069354</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38648275</guid>
<pubDate>Mon, 22 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Jay Giri</dc:creator>
<dc:creator>Tsuyoshi Kaneko</dc:creator>
<dc:date>2024-04-22</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Much Ado About Nothing? CABG or PCI for Left Main Coronary Artery Disease</dc:title>
<dc:identifier>pmid:38648275</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069354</dc:identifier>
</item>
<item>
<title>Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38648274/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 23;149(17):1323-1325. doi: 10.1161/CIRCULATIONAHA.123.066988. Epub 2024 Apr 22.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38648274/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38648274</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066988>10.1161/CIRCULATIONAHA.123.066988</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38648274</guid>
<pubDate>Mon, 22 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Svati H Shah</dc:creator>
<dc:creator>Robert E Gerszten</dc:creator>
<dc:date>2024-04-22</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Sifting for Gold in Terabytes of Data: Illuminating Cardiovascular Biology in the 'Omics Age</dc:title>
<dc:identifier>pmid:38648274</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066988</dc:identifier>
</item>
<item>
<title>Trends in Age, Sex, and Racial Differences in the Incidence of Infective Endocarditis in Florida and New York</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38648273/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 23;149(17):1391-1393. doi: 10.1161/CIRCULATIONAHA.123.066921. Epub 2024 Apr 22.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38648273/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38648273</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066921>10.1161/CIRCULATIONAHA.123.066921</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38648273</guid>
<pubDate>Mon, 22 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Anderson Anuforo</dc:creator>
<dc:creator>Ehimen Aneni</dc:creator>
<dc:creator>Emmanuel Akintoye</dc:creator>
<dc:creator>Nnabuchi Anikpezie</dc:creator>
<dc:creator>Smit D Patel</dc:creator>
<dc:creator>Ayorinde Soipe</dc:creator>
<dc:creator>Eloho Olojakpoke</dc:creator>
<dc:creator>Devin Burke</dc:creator>
<dc:creator>Julius Gene Latorre</dc:creator>
<dc:creator>Priyank Khandelwal</dc:creator>
<dc:creator>Seemant Chaturvedi</dc:creator>
<dc:creator>Bruce Ovbiagele</dc:creator>
<dc:creator>Fadar Oliver Otite</dc:creator>
<dc:date>2024-04-22</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Trends in Age, Sex, and Racial Differences in the Incidence of Infective Endocarditis in Florida and New York</dc:title>
<dc:identifier>pmid:38648273</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066921</dc:identifier>
</item>
<item>
<title>Autonomic Dysfunction Linked to Inhibition of the Na&lt;sub>;v&lt;/sub>;1.7 Sodium Channel</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38648272/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 23;149(17):1394-1396. doi: 10.1161/CIRCULATIONAHA.123.067331. Epub 2024 Apr 22.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38648272/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38648272</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067331>10.1161/CIRCULATIONAHA.123.067331</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38648272</guid>
<pubDate>Mon, 22 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Christopher P Regan</dc:creator>
<dc:creator>Pierre Morissette</dc:creator>
<dc:creator>Richard L Kraus</dc:creator>
<dc:creator>Erjia Wang</dc:creator>
<dc:creator>Leticia Arrington</dc:creator>
<dc:creator>Marissa Vavrek</dc:creator>
<dc:creator>Jan de Hoon</dc:creator>
<dc:creator>Marleen Depre</dc:creator>
<dc:creator>Thomas Lodeweyck</dc:creator>
<dc:creator>Ignace Demeyer</dc:creator>
<dc:creator>Tine Laethem</dc:creator>
<dc:creator>Aubrey Stoch</dc:creator>
<dc:creator>Arie Struyk</dc:creator>
<dc:date>2024-04-22</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Autonomic Dysfunction Linked to Inhibition of the Na&lt;sub>;v&lt;/sub>;1.7 Sodium Channel</dc:title>
<dc:identifier>pmid:38648272</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067331</dc:identifier>
</item>
<item>
<title>Making House Calls</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38648271/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Apr 23;149(17):1326-1327. doi: 10.1161/CIRCULATIONAHA.123.068553. Epub 2024 Apr 22.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38648271/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38648271</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068553>10.1161/CIRCULATIONAHA.123.068553</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38648271</guid>
<pubDate>Mon, 22 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Laurence Sperling</dc:creator>
<dc:date>2024-04-22</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Making House Calls</dc:title>
<dc:identifier>pmid:38648271</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068553</dc:identifier>
</item>
<item>
<title>New light shed on Anderson-Fabry, peripartum, and early-onset cardiomyopathies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38643479/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Apr 21;45(16):1379-1383. doi: 10.1093/eurheartj/ehae226.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38643479/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38643479</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae226>10.1093/eurheartj/ehae226</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38643479</guid>
<pubDate>Sun, 21 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-04-21</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>New light shed on Anderson-Fabry, peripartum, and early-onset cardiomyopathies</dc:title>
<dc:identifier>pmid:38643479</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae226</dc:identifier>
</item>
<item>
<title>Self-expanding valves more beneficial than balloon-expandable valves in patients with a small aortic annulus</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38641756/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Apr 19. doi: 10.1038/s41569-024-01027-9. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38641756/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38641756</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01027-9>10.1038/s41569-024-01027-9</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38641756</guid>
<pubDate>Fri, 19 Apr 2024 06:00:00 -0400</pubDate>
<dc:creator>Karina Huynh</dc:creator>
<dc:date>2024-04-19</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Self-expanding valves more beneficial than balloon-expandable valves in patients with a small aortic annulus</dc:title>
<dc:identifier>pmid:38641756</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01027-9</dc:identifier>
</item>
<item>
<title>Retraction of: Abstract 13079: Prevalence and Incidence of Transthyretin Amyloid Cardiomyopathy in the USA From 2004 to 2022: An Observational Database Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38639556/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 26;149(13):e1027. doi: 10.1161/CIR.0000000000001239. Epub 2024 Mar 25.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38639556/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38639556</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001239>10.1161/CIR.0000000000001239</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38639556</guid>
<pubDate>Fri, 19 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-19</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Retraction of: Abstract 13079: Prevalence and Incidence of Transthyretin Amyloid Cardiomyopathy in the USA From 2004 to 2022: An Observational Database Study</dc:title>
<dc:identifier>pmid:38639556</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001239</dc:identifier>
</item>
<item>
<title>Correction to: 2023 Scientific Sessions Abstract 18539</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38639555/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240424021239&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 26;149(13):e1025. doi: 10.1161/CIR.0000000000001237. Epub 2024 Mar 25.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38639555/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240424021239&v=2.18.0.post9+e462414">38639555</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001237>10.1161/CIR.0000000000001237</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38639555</guid>
<pubDate>Fri, 19 Apr 2024 06:00:00 -0400</pubDate>
<dc:date>2024-04-19</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 Scientific Sessions Abstract 18539</dc:title>
<dc:identifier>pmid:38639555</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001237</dc:identifier>
</item>





























</channel>
</rss>